An apple a day is all fine and good. But what about a potato? Or more precisely, a raw potato to fight chronic kidney disease.
Thatâ€™s at the heart of a soon-to-be-launched clinical trial of a made-in-Manitoba dietary supplement consisting of whatâ€™s called a resistant starch.
The initiative comes out of one of the worldâ€™s leading centres for chronic kidney disease research, the Chronic Disease Innovation Centre at Seven Oaks General Hospital. And itâ€™s the brainchild of nutrition and lifestyle researcher, Dylan Mackay, a University of Manitoba associate professor of community health sciences.
“Weâ€™re testing a product thatâ€™s made in Carberry to see if it can assist with a problem that we have an over-representation of in Manitoba.”
The product, called MSPrebiotic, is manufactured in Carberry and it largely consists of whatâ€™s called resistant starch, which is derived from raw potatoes.
Already another Manitoba-based study has shown the supplement offers promise in managing blood-glucose levels and reducing insulin resistance, a key cause of Type 2 diabetes â€” which also happens to be a key culprit in chronic kidney disease.
“What we also saw was an increase in… good bacteria… and a decrease in the bad bacteria,” says Jason Leibert, vice-president of business development for MSPrebiotic. “Basically it showed that it can have a positive impact on your microbiome.”